The OLANI has not been approved for sale by TGA, FDA or any other Regulatory Authority.
The following resources are for information only, for the use of the OLANI under a Named Patient Program (NPP), compassionate use program or special access scheme, which allows patients with critical, life-threatening conditions to access potentially life-saving, but unapproved, therapeutic options in an ethical and regulated manner.
